Power poses may boost anxiety therapy, study finds
NCT ID NCT02482805
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether holding powerful poses before exposure therapy can increase testosterone levels and make treatment for social anxiety more effective. 73 adults with social anxiety disorder participated. The goal was to see if this simple change could help people feel less anxious in social situations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
73 people
The number who actually took part.
- Start date
-
Jul 2015
- Finished
-
Apr 2017
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 70 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Outpatients between the ages of 18 to 70 years of age with a primary psychiatric diagnosis (designated by the patient as the most important source of current distress) of social anxiety disorder as defined by DSM-5 criteria, with fear of public speaking endorsed as a primary concern. * Willingness and ability to participate in the informed consent process and comply with the requirements of the study protocol. Exclusion Criteria: * Current use of testosterone enhancing products (i.e., gels, creams, or injections) * A lifetime history of bipolar disorder, schizophrenia, psychosis, or delusional disorders; organic brain syndrome, mental retardation or other cognitive dysfunction that could interfere with capacity to engage in therapy; a history of substance or alcohol abuse or dependence (other than nicotine) in the last 6 months. * Entry of patients with other mood or anxiety disorders will be permitted in order to increase accrual of a clinically relevant sample; however in cases where SAD is not judged to be the predominant disorder, participants will not be eligible. * Patients with significant suicidal ideation or who have enacted suicidal behaviors within 6 months prior to intake will be excluded from study participation and referred for appropriate clinical intervention. * Patients using psychotropic medication (e.g., antidepressants, anxiolytics, beta blockers) must be on a stable dose for three weeks prior to initiation of randomized treatment. * Significant personality dysfunction likely to interfere with study participation. * Patients with a current or past history of seizures. * Any concurrent psychotherapy initiated within 3 months of baseline, or ongoing psychotherapy of any duration directed specifically toward treatment of the SAD is excluded. Prohibited psychotherapy includes CBT or psychodynamic therapy focusing on exploring specific, dynamic causes of the phobic symptomatology and providing management skills. General supportive therapy initiated \> 3 months prior is acceptable. * Prior non-response to adequately delivered exposure (i.e., as defined by the patient's report of receiving specific and regular exposure assignments as part of a previous treatment). * Patients with a history of head trauma causing loss of consciousness, seizure or ongoing cognitive impairment. * Subjects with back pain issues or medical conditions that would make it difficult to hold posture manipulations. * Insufficient command of the English language.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Social anxiety disorder are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Texas at Austin
Austin, Texas, 78712, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a computer game rewire anxious Kids' brains?
- Can tailored brain stimulation quiet anxiety that drugs Can't?
- Can meditation rewire the anxious social brain?
- One-Size-Fits-All anxiety therapy may be a thing of the past
- Ear-Zapping device may tame social anxiety — trial puts it to the test
- Can an AI coach help therapists treat depression and anxiety online?